ArticleCancers2022

Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.

Jina Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.